Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide plus atazanavir
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide plus atazanavir, covering 2017-06-12 to 2017-06-12. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults [Phase 3]